Quantitative magnetic resonance imaging in multiple sclerosis: the effect of high dose intravenous methylprednisolone (Q31080169)

3 November 2017

Quantitative magnetic resonance imaging in multiple sclerosis: the effect of high dose intravenous methylprednisolone (English)

1 reference

3 November 2017

0 references

1 reference

Kesselring J

1

1 reference

3 November 2017

Miller DH

2

1 reference

3 November 2017

MacManus DG

3

1 reference

3 November 2017

Johnson G

4

1 reference

3 November 2017

Milligan NM

5

1 reference

3 November 2017

Scolding N

6

1 reference

3 November 2017

Compston DA

7

1 reference

3 November 2017

McDonald WI

8

1 reference

3 November 2017

language of work or name

English

0 references

publication date

1 January 1989

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

3 November 2017

1 reference

3 November 2017

52

1 reference

3 November 2017

1

1 reference

3 November 2017

14-17

1 reference

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

3 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032649

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032649

Biomedical implications of the relaxation behaviour of water related to NMR imaging

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032649

Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH vs. placebo--final report

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032649

Accuracy and precision in the measurement of relaxation times from nuclear magnetic resonance images

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032649

Spin-lattice relaxation (T1) times of cerebral white matter in multiple sclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032649

The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032649

In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032649

The characterization of experimental gliosis by quantitative nuclear magnetic resonance imaging

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032649

Intravenous methylprednisolone for multiple sclerosis in relapse

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032649

A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 2. Laboratory results

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032649

The mystery of the origin of multiple sclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032649

Optic nerve fibre lesions in adult cats: pattern of recovery of spatial vision

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032649

A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032649

Pathophysiology of demyelinating disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032649

Cranial Computed Tomography (CCT) Findings in Children Treated with ACTH and Dexamethasone: First Results

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032649

Some Spaces and Barriers in Postmortem Multiple Sclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032649

Possible beneficial effect of high-dose intravenous steroid therapy in acute demyelinating disease and transverse myelitis

25 November 2018

1 reference

12 December 2020

Computed tomography in acute cerebral multiple sclerosis. A report of two cases

1 reference

12 December 2020

Effect of high-dose intravenous steroid administration on contrast-enhancing computed tomographic scan lesions in multiple sclerosis

1 reference

12 December 2020

The effect of dexamethasone on L-alpha-lysophosphatidyl choline (lysolecithin)-induced demyelination of the rat spinal cord

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.52.1.14

1 reference

3 November 2017

1 reference

3 November 2017

PubMed publication ID

2709033

1 reference